BD推出具有突破性光谱和实时细胞成像技术的里程碑式细胞分析仪-动脉网

BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies

碧迪医疗等信源发布 2025-05-13 20:15



可切换为仅中文







New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma

全新BD FACSDiscover™ A8细胞分析仪为学术界和生物制药领域的更广泛科学家带来前沿功能

FRANKLIN LAKES, N.J.

弗兰克林湖，新泽西州

，

May 13, 2025

2025年5月13日

PRNewswire

美通社

/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, enabling more researchers across a wider range of applications to uncover deeper insights and dynamics from cells once invisible in flow cytometry experiments – with increased ease and throughput..

/ -- BD（Becton, Dickinson and Company）（纽约证券交易所代码：BDX），一家全球领先的医疗技术公司，宣布在全球范围内商业化推出全球首款结合突破性光谱技术和实时细胞成像技术的细胞分析仪，使更多研究人员能够通过更广泛的应用，揭示以往在流式细胞术实验中无法看到的细胞深层次信息和动态变化 —— 同时提升了操作便利性和检测通量。

BD SpectralFX™ Technology maximizes the number of colors that can be used in flow cytometry, allowing scientists to analyze up to 50 or more characteristics of a single cell at one time, with optimal resolution and sensitivity, which is ideal for scientists pursuing novel biomarker discovery. BD CellView™ Image Technology enables high-speed fluorescent and label-free imaging of single cells, revealing precise spatial and morphological insights – like the location of a virus or protein within a single cell, or the microscopic interaction between two cells – that can be visually confirmed and analyzed in real time.

BD SpectralFX™ 技术最大限度地增加了流式细胞术中可用的颜色数量，使科学家能够同时分析单个细胞多达50种或更多特征，具有最佳的分辨率和灵敏度，非常适合致力于新型生物标志物发现的科学家。BD CellView™ 图像技术实现了单细胞的高速荧光和无标记成像，揭示精确的空间和形态学信息——例如病毒或蛋白质在单个细胞内的位置，或者两个细胞之间的微观相互作用——这些都可以实时进行视觉确认和分析。

Combining these technologies, which were first introduced in the BD FACSDiscover™ S8 Cell Sorter and profiled on the cover of the journal .

结合这些技术，它们最初是在BD FACSDiscover™ S8细胞分选仪中引入，并在期刊封面上进行了介绍。

Science

科学

，

the BD FACSDiscover™ A8 Cell Analyzer enables scientists to capture more insights per experiment than ever, with exceptional depth, speed and sensitivity.

BD FACSDiscover™ A8 细胞分析仪使科学家能够以非凡的深度、速度和灵敏度在每次实验中获取更多的见解。

Additional advancements on the BD FACSDiscover™ A8 Cell Analyzer are specifically designed to power translational research. Highlights include:

BD FACSDiscover™ A8 细胞分析仪的更多进展专为推动转化研究而设计。亮点包括：

High-throughput, walkaway automation that enables best-in-class cost-per-insight economics

高通量、无需人工干预的自动化技术，实现业内最佳的单次洞察成本效益

New intuitive software workflows that allow for effective management of large datasets, for improved system usability

新直观的软件工作流程，能够有效管理大型数据集，从而提高系统的可用性。

Seamless pairing with the industry-leading ecosystem of BD FACSDiscover™ Cell Sorters and BD Reagents

与行业领先的BD FACSDiscover™细胞分选仪和BD试剂生态系统无缝配对

'The BD FACSDiscover™ A8 Cell Analyzer signals an exciting step forward for researchers in areas like immuno-oncology that require tools delivering excellent reproducibility and performance, while managing budget constraints,' said

“BD FACSDiscover™ A8细胞分析仪标志着一个令人兴奋的进步，对于免疫肿瘤学等领域需要具备优异可重复性和性能、同时管理预算限制的研究人员而言意义重大，”表示

Rui Gardner

鲁伊·加德纳

, head of Flow Cytometry Core Facility at Memorial Sloan Kettering Cancer Center, an early access collaboration site. 'Our investigators have already learned so much using this new technology, and we look forward to performing deep immunophenotyping for high-fidelity biomarker discovery to elucidate insights that can advance research and improve human health.'.

纪念斯隆凯特琳癌症中心流式细胞术核心设施负责人，早期访问合作站点。 “我们的研究人员使用这项新技术已经学到了很多东西，我们期待利用高保真生物标志物发现进行深度免疫表型分析，以阐明能够推动研究和改善人类健康的观点。”

Steve Conly

史蒂夫·康利

, worldwide president of BD Biosciences, added, 'Translational research, in particular, is growing at a rapid pace and the BD FACSDiscover™ A8 Cell Analyzer combines advanced science with ease of use to empower, like never before, scientists developing the next generation of potentially life-changing therapies.

BD生物科学全球总裁补充道：“转化研究尤其以快速的步伐增长，BD FACSDiscover™ A8细胞分析仪将先进科学与易用性相结合，以前所未有的方式赋能正在开发下一代可能改变生命疗法的科学家。”

Paired with the BD FACSDiscover™ S8 Cell Sorter, and alongside our advancements in software, informatics, and reagents, this landmark cell analyzer will enable new dimensions of possibilities in one state-of-the-art ecosystem.'.

与BD FACSDiscover™ S8细胞分选仪配合使用，并结合我们在软件、信息学和试剂方面的进步，这款具有里程碑意义的细胞分析仪将在一个先进的生态系统中开启新的可能性维度。

New software innovations launching alongside the instrument include the latest version of BD FACSChorus™ Software, which simplifies workflows on both the BD FACSDiscover™ A8 Cell Analyzer as well as FACSDiscover™ S8 Cell Sorter, and the faster, easier-to-use analysis software FlowJo™ v11. All three products will be featured at the International Society for Advancement of Cytometry CYTO 2025 event at booth 615 from .

与该仪器一同推出的全新软件创新包括最新版本的BD FACSChorus™软件，它简化了BD FACSDiscover™ A8细胞分析仪和FACSDiscover™ S8细胞分选仪的工作流程，以及更快速、更易用的分析软件FlowJo™ v11。这三款产品都将在国际细胞计量学促进会CYTO 2025展会的615号展位展出。

May 31 to June 4

5月31日至6月4日

在

Denver

丹佛

. The BD FACSDiscover™ A8 Cell Analyzer is now available to order through local sales representatives, and through a forthcoming FACSDiscover™ Partner Program initially in select regions that gives customers added flexibility and support. More information is available at

BD FACSDiscover™ A8 细胞分析仪现在可以通过当地销售代表订购，并通过即将推出的 FACSDiscover™ 合作伙伴计划在部分区域率先提供，该计划为客户提供更多灵活性和支持。更多信息可访问

bdbiosciences.com

。

About BD

关于BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.

BD是全球最大的医疗技术公司之一，通过改进医疗发现、诊断和护理服务来推动健康领域的发展。该公司通过开发创新的技术、服务和解决方案，支持医疗保健领域的前线英雄，帮助推进患者的临床治疗和医疗服务提供者的临床流程。

BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics.

BD及其超过70,000名员工充满热情并致力于帮助提升临床医生护理流程的安全性和效率，使实验室科学家能够准确检测疾病，并推动研究人员开发下一代诊断和治疗手段的能力。

BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

BD几乎在每个国家都有业务，并与世界各地的组织合作，应对一些最具挑战性的全球健康问题。通过与客户紧密合作，BD能够帮助改善结果、降低成本、提高效率、增强安全性并扩大医疗保健的可及性。

For more information on BD, please visit .

有关BD的更多信息，请访问。

bd.com

or connect with us on LinkedIn at

或者在LinkedIn上与我们联系

www.linkedin.com/company/bd1/

, X (formerly Twitter)

，X（原名Twitter）

@BDandCo

or Instagram

或 Instagram